COMP <GO>
HRMY vs XNCR // EV/EBITDA & P/E VALUATION
Harmony Biosciences Holdings Inc. (NASDAQ) VS. Xencor Inc. (NASDAQ) • 15-METRIC TALLY: HRMY 8
— XNCR 1
■ METRIC PARITY
LAST: $38.76 (+0.44%) • MKT CAP: $2.26B
valuation
7.8x
LAST: $29.82 (+2.09%) • MKT CAP: $2.22B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HRMY VS. XNCR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HRMY | XNCR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 77.20% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 63.00% | -21.30% | +84.30 | HRMY | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 7.8x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 15.48% | -6.37% | +21.85 | HRMY | /fcf-yield <GO> |
| Operating Margin | 24.00% | -60.00% | +84.00 | HRMY | /operating-margins <GO> |
| Net Profit Margin | 18.30% | -60.00% | +78.30 | HRMY | /net-margins <GO> |
| Revenue Growth (YoY) | 21.50% | 13.70% | +7.80 | HRMY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.38 | 4.32 | +1.06 | HRMY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 4/9 | +5.00 | HRMY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.1 | 66.2 | -15.10 | XNCR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 11.9x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.26B | $2.22B | $40.0M | HRMY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HRMY REV | XNCR REV | HRMY GROSS % | XNCR GROSS % | HRMY FCF | XNCR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $868.5M | $125.6M | 77.2% | — | $347.9M | -$138.3M |
| FY 2024 | $714.7M | $110.5M | 78.1% | — | $218.7M | -$208.3M |
| FY 2023 | $582.0M | $174.6M | — | — | $219.4M | -$77.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HRMY // BETA —
XNCR // BETA —